series-b
Stage
1
Investors
About
Orionis Biosciences is a clinical-stage life sciences company developing precision medicines using molecular glues, cytokines, and cell engagers to modulate protein and immune cell interactions for cancer therapy.
Explore Orionis Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.